Xiao-Nan Wang

Xiao-Nan Wang

Auto-generated profile, based on publicly available information

Xiao-Nan Wang

Laboratory of Pathogenic Microbiology and Immunology, School of Basic Medicine, Anhui Medical University, Hefei, Anhui, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZWZhengsheng Wu
Zhengsheng Wu
QWQiang Wu
Qiang Wu
CWChao-Qun Wang
Chao-Qun Wang
XWXiao-Nan Wang
Xiao-Nan Wang
YWYan Wang
Yan Wang
XXXiao-Chun Xu
Xiao-Chun Xu
MicroRNAs (miRNAs) play an important role in the regulation of cell growth, differentiation, apoptosis, and carcinogenesis. Detection of their expression may lead to identifying novel markers for breast cancer.

1 February 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
ZWZhengsheng Wu
Zhengsheng Wu
CWChao-Qun Wang
Chao-Qun Wang
RXRu Xiang
Ru Xiang
XLXue Liu
Xue Liu
SYShan Ye
Shan Ye
QWQiang Wu
Qiang Wu
MiRNAs, endogenous oligonucleotide RNAs, play an important role in mammary gland carcinogenesis and tumor progression. Detection of their expression and investigation of their functions could lead to discovery of novel biomarkers for breast cancer.

10 June 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
QWQiang Wu
Qiang Wu
XLXue Liu
Xue Liu
HYHong Yan
Hong Yan
YHYin-Huan He
Yin-Huan He
SYShan Ye
Shan Ye
ZWZhengsheng Wu
Zhengsheng Wu
B-cell lymphoma 6 (BCL6) protein, an evolutionarily conserved zinc finger transcription factor, showed to be highly expressed in various human cancers in addition to malignancies in the lymphoid system. This study investigated the role of BCL6 expression in breast cancer and its clinical significance in breast cancer patients. Expression of BCL6 protein was assessed using in situ hybridization and immunohistochemistry in 127 breast cancer patients and 50 patients with breast benign disease as well as in breast cell lines. Expression of BCL6 was restored or knocked down in two breast cancer cell lines (MCF-7 and T47D) using BCL6 cDNA and siRNA, respectively. The phenotypic change of these breast cancer cell lines was assessed using cell viability MTT, Transwell invasion, colony formation, and flow cytometry assays and in a xenograft mice model. Luciferase reporter gene, immunoblot, and qRT-PCR were used to investigate the molecular events after manipulated BCL6 expression in breast cancer cells. BCL6 protein was highly expressed in breast cancer cell lines and tissue specimens and expression of BCL6 protein was associated with disease progression and poor survival of breast cancer patients. In vitro, the forced expression of BCL6 results in increased proliferation, anchorage-independent growth, migration, invasion and survival of breast cancer cell lines, whereas knockdown of BCL6 expression reduced these oncogenic properties of breast cancer cells. Moreover, forced expression of BCL6 increased tumor growth and invasiveness in a nude mouse xenograft model. At the gene level, BCL6 was a target gene of miR-339-5p. Expression of BCL6 induced expression of CXCR4 and cyclinD1 proteins. The current study demonstrated the oncogenic property of BCL6 in breast cancer and further study could target BCL6 as a novel potential therapeutic strategy for breast cancer.

1 January 2018
Verified
Journal Article
Closed access
KDKeshuo Ding
Keshuo Ding
ZWZhengsheng Wu
Zhengsheng Wu
XLXiaocan Li
Xiaocan Li
YSYoujing Sheng
Youjing Sheng
XWXiaonan Wang
Xiaonan Wang
STSheng Tan
Sheng Tan

1 January 2026 in Research
Verified
Journal Article
Open access
HWHao Wang
Hao Wang
QGQianying Guo
Qianying Guo
YSYuting Shen
Yuting Shen
KDKeshuo Ding
Keshuo Ding
YCYinfeng Chen
Yinfeng Chen
ZWZhengsheng Wu
Zhengsheng Wu
Apoptosis and autophagy are fundamental pathophysiological programs governing cell fate decisions under stress, particularly during anticancer therapy. However, the interplay between apoptosis and autophagy in cancer chemoresistance remains incompletely understood. Here, we identify the apoptosis-related protein in the transforming growth factor-β signaling pathway (ARTS) as a key molecular transferring apoptotic signal to autophagic machinery to promote cell survival and chemoresistance. ARTS was highly expressed in chemoresistant breast cancer tissues and was associated with poor patient prognosis. ARTS conferred resistance to doxorubicin and docetaxel by inducing protective autophagy in vitro and in vivo cancer models. Mechanistically, upon proapoptotic signaling triggered by chemotherapeutic agents, ARTS translocated from the mitochondrial intermembrane space into the cytosol, where it induced autophagy through triggering seven in absentia homolog 1-mediated degradation of Livin and subsequent engagement of the mouse double minute 2 homolog (MDM2)–p53 axis, thereby promoting cancer cell survival. Pharmacologic inhibition of caspases or autophagic flux attenuated ARTS-mediated chemoresistance. Overall, this study delineates an apoptosis-dependent ARTS–Livin–MDM2–p53 pathway that drives autophagy and confers chemoresistance in breast cancer.